Background And Objective: The global prevalence of diabetes mellitus has markedly risen in recent years. Consequently, there has been a rise in the number of patients with diabetes undergoing cardiac surgery. Despite the existence of national and international guidelines to improve surgical outcomes in patients with diabetes, perioperative diabetes management optimisation remains inadequate resulting in these patients experiencing increased rates of surgical morbidity and mortality. This review aims to evaluate outcomes following cardiac surgery in patients with diabetes and assess strategies to enhance preoperative and perioperative optimization and postoperative outcomes.

Methods: A comprehensive literature search was performed for articles concerning perioperative management of diabetes in patients undergoing cardiac surgery as well as postoperative complications related to diabetes in addition to interventions utilised to optimize outcomes.

Key Content And Findings: Principle findings were extracted and synthesized. Patients with diabetes undergoing cardiac surgery exhibit increased perioperative complications, higher in-hospital mortality rates and inferior long-term survival. A key facilitator is specifically poor glycemic control, with glycated haemoglobin (HbA1c) serving as a predictive marker. However, measuring preoperative HbA1c is not routine, and there is no established threshold for deferring elective surgery. Preoperatively, emphasis should be placed on lowering the patient's HbA1c through optimized medical management and continuous glucose monitoring. Intraoperatively, continuous insulin infusion therapy is recommended alongside postoperative continuation for critically ill patients. Prompt resumption of the patient's routine medications post-surgery is also necessary.

Conclusions: Optimal glycemic control, both pre-, intra- and perioperatively, correlates with improved outcomes that are comparable to those without diabetes. Targeted efforts are warranted for patients with diabetes undergoing cardiac surgery to ensure long-term benefits for the patients and healthcare systems.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635245PMC
http://dx.doi.org/10.21037/jtd-24-1112DOI Listing

Publication Analysis

Top Keywords

cardiac surgery
24
undergoing cardiac
20
patients diabetes
20
diabetes undergoing
12
patients
10
diabetes
10
patients undergoing
8
glycemic control
8
surgery
7
cardiac
6

Similar Publications

Introduction: Antibody-drug conjugates (ADCs) trastuzumab-deruxtecan (T-DXd) and sacituzumab-govitecan (SG) provided significant progression-free survival (PFS) and overall survival (OS) improvements over chemotherapy (CT) in pretreated hormone receptor-positive (HR+) and triple-negative (TN)/HER2-low metastatic breast cancer (MBC). However, no direct comparison between the two exists, nor with the more recent datopotamab-deruxtecan (Dato-DXd).

Methods: We conducted a network meta-analysis (NMA) to compare efficacy and safety of T-DXd and SG in CT-pretreated HR+ and TN/HER2-low MBC and assess their benefit over standard CT, exploring also a comparison with Dato-DXd.

View Article and Find Full Text PDF

Screening and identification of antimicrobial peptides from the gut microbiome of cockroach Blattella germanica.

Microbiome

December 2024

MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, Liaoning, 116024, China.

Background: The overuse of antibiotics has led to lethal multi-antibiotic-resistant microorganisms around the globe, with restricted availability of novel antibiotics. Compared to conventional antibiotics, evolutionarily originated antimicrobial peptides (AMPs) are promising alternatives to address these issues. The gut microbiome of Blattella germanica represents a previously untapped resource of naturally evolving AMPs for developing antimicrobial agents.

View Article and Find Full Text PDF

Introduction: Recent international consensus statements advocate for the integration of Point-of-Care Ultrasound (PoCUS) into the global undergraduate medical curriculum. Some medical schools outside Saudi Arabia have already incorporated PoCUS into their undergraduate curricula to enhance anatomy, physiology and pathology instruction. However, there are no data on the potential role of PoCUS in the preclinical training of medical students in Saudi Arabia.

View Article and Find Full Text PDF

Enhanced Recovery After Surgery (ERAS) is a cost-effective perioperative approach that has been shown to shorten patients' hospital length of stay, improve resource utilization, and reduce postoperative costs for both patients and hospitals. While ERAS has the potential to offer even greater benefits in low- and middle-income countries (LMICs) its successful long-term implementation remains incomplete in Pakistan. This study aimed to explore insights and identify opportunities for implementing ERAS within the local socio-environmental context.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!